Clinical Trial Update: Efficacy and Safety of Disitamab Vedotin Combined With Sintilimab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating disitamab vedotin in combination with sintilimab for gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)
• Sintilimab (sintilimab)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN